![Michael Martin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Martin
Chief Executive Officer at
Plexium, Inc.
Profile
Michael Martin is President, Chief Executive Officer & Director at Plexium, Inc. since 2024.
Dr. Martin is Director at BioMotiv LLC, Bioniz Therapeutics, Inc., OrphoMed, Inc., Ambys Medicines, Inc., and Abintus Bio, Inc. Former roles include Director-Pharmaceutical Properties Assessment at TargeGen, Inc., Independent Director at Avidity Biosciences, Inc. from 2016 to 2021, Director-Preclinical Development at Intellikine LLC, Director at Univercells SA and Palleon Pharmaceuticals, Inc., Principal at Arena Pharmaceuticals, Inc. and Monsanto Co., Member-Global Licensing & Business Development at Takeda Pharmaceutical Co., Ltd. from 2012 to 2015, and Principal at G.D.
Searle LLC.
Education includes undergraduate and graduate degrees from St. Louis University and a doctorate from the University of Illinois.
Michael Martin active positions
| Companies | Position | Start |
|---|---|---|
OrphoMed, Inc.
 OrphoMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Director/Board Member | - |
BioMotiv LLC
 BioMotiv LLC BiotechnologyHealth Technology Operates as a research institution in the field of therapeutics | Director/Board Member | - |
Bioniz Therapeutics, Inc.
 Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company | Director/Board Member | - |
Ambys Medicines, Inc.
 Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Develops regenerative medicine therapies for serious liver diseases | Director/Board Member | - |
Abintus Bio, Inc.
 Abintus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage gene therapy company | Director/Board Member | - |
Plexium, Inc.
 Plexium, Inc. BiotechnologyHealth Technology Develops drug discovery and targeted protein degradation therapeutics technology platform | Chief Executive Officer | 2024-01-15 |
Former positions of Michael Martin
| Companies | Position | End |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Director/Board Member | 2021-01-10 |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Director/Board Member | 2018-06-20 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 2015-03-31 |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Michael Martin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
68
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Monsanto Co.
 Monsanto Co. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company controlling insects and weeds & manufactures seeds and genomics | Commercial Services |
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures vascular biopharmaceutical products | Health Technology |
BioMotiv LLC
BioMotiv LLC BiotechnologyHealth Technology Operates as a research institution in the field of therapeutics | Health Technology |
Bioniz Therapeutics, Inc.
Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company | Commercial Services |
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
St. Louis University
 St. Louis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellikine LLC
 Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Health Technology |
G.D. Searle LLC | |
Univercells SA
 Univercells SA Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences company which develops biologics | Commercial Services |
OrphoMed, Inc.
OrphoMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Health Technology |
Ambys Medicines, Inc.
Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Develops regenerative medicine therapies for serious liver diseases | Health Technology |
Plexium, Inc.
Plexium, Inc. BiotechnologyHealth Technology Develops drug discovery and targeted protein degradation therapeutics technology platform | Health Technology |
Abintus Bio, Inc.
Abintus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage gene therapy company | Commercial Services |
- Stock Market
- Insiders
- Michael Martin
